المؤلفون: Dorofeeva MN, Shikh EV, Sizova ZM, Tarasenko AV, Denisenko NP, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA, Sychev DA

المصدر: Pharmacogenomics and Personalized Medicine, Vol Volume 12, Pp 329-339 (2019)

مصطلحات موضوعية: cyp2c19, cyp3a, pharmacogenetics, proton pump inhibitor, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/antihypertensive-effect-of-amlodipine-in-co-administration-with-omepra-peer-reviewed-article-PGPM; https://doaj.org/toc/1178-7066

URL الوصول: https://doaj.org/article/6dd41a36e2694f28a035a0ca1e4ad3c3

المؤلفون: Denisenko NP, Sychev DA, Sizova ZM, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA

المصدر: Pharmacogenomics and Personalized Medicine, Vol Volume 11, Pp 107-112 (2018)

مصطلحات موضوعية: pharmacogenetics, phenotyping, metabolomics, proton pump inhibitor, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/cyp3a-and-cyp2c19-activity-in-urine-in-relation-to-cyp3a4-cyp3a5-and-c-peer-reviewed-article-PGPM; https://doaj.org/toc/1178-7066

URL الوصول: https://doaj.org/article/d830c3efca6e496ea50e8a38e96b7d59

المؤلفون: Denisenko NP, Sychev DA, Sizova ZM, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Grishina EA

المصدر: Pharmacogenomics and Personalized Medicine, Vol Volume 10, Pp 253-259 (2017)

مصطلحات موضوعية: pharmacogenetics, phenotyping, metabolomics, proton pump inhibitor, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/urine-metabolic-ratio-of-omeprazole-in-relation-to-cyp2c19-polymorphis-peer-reviewed-article-PGPM; https://doaj.org/toc/1178-7066

URL الوصول: https://doaj.org/article/88651be642a44495ba987f336fc4c951

المؤلفون: Sychev DA, Shuev GN, Suleymanov SS, Ryzhikova KA, Mirzaev KB, Grishina EA, Snalina NE, Sozaeva ZA, Grabuzdov AM, Matsneva IA

المصدر: Pharmacogenomics and Personalized Medicine, Vol Volume10, Pp 93-99 (2017)

مصطلحات موضوعية: Pharmacogenetics, ethnicity, Asians, Europeans, the SNP, the P450 cytochrome, ethnic group, P-glycoprotein, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/comparison-of-cyp2c9-cyp2c19-cyp2d6-abcb1-and-slco1b1-gene-polymorphis-peer-reviewed-article-PGPM; https://doaj.org/toc/1178-7066

URL الوصول: https://doaj.org/article/ca76ac84bc7e4a7b80afe268de992495

المؤلفون: Rytkin E, Mirzaev KB, Grishina EA, Smirnov VV, Ryzhikova KA, Sozaeva ZA, Giliarov MI, Andreev DA, Sychev DA

المصدر: Pharmacogenomics and Personalized Medicine, Vol Volume 10, Pp 243-245 (2017)

مصطلحات موضوعية: Acute Coronary Syndrome, Clopidogrel, Complications, Polymorphism, Stents, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/do-cyp2c19-and-abcb1-gene-polymorphisms-and-low-cyp3a4-isoenzyme-activ-peer-reviewed-article-PGPM; https://doaj.org/toc/1178-7066

URL الوصول: https://doaj.org/article/e8aef19253504f0687800fd09afcc875

المؤلفون: Gurieva OD; Department of Pediatric Oncology and Hematology Research Institute, N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia, Moscow, Russia., Savelyeva MI; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia., Valiev TT; Department of Pediatric Oncology and Hematology Research Institute, N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia, Moscow, Russia.; Department of Oncology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia., Sozaeva ZA; Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Kondratenko SN; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia., Ilyin MV; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia.

المصدر: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2023 Dec 14; Vol. 38 (4), pp. 349-357. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: eCollection Cited Medium: Internet ISSN: 2363-8915 (Electronic) Linking ISSN: 23638915 NLM ISO Abbreviation: Drug Metab Pers Ther Subsets: MEDLINE

مواضيع طبية MeSH: Methotrexate*/adverse effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics, Child ; Humans ; Polymorphism, Single Nucleotide ; Pharmacogenetics ; Risk Factors ; Genotype ; Liver-Specific Organic Anion Transporter 1/genetics

المؤلفون: Golubenko EO; Department of Obstetrics and Gynecology, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Savelyeva MI; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia., Sozaeva ZA; Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Korennaya VV; Department of Obstetrics and Gynecology, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Poddubnaya IV; Oncology Department, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia, Moscow, Russia., Valiev TT; Department of Pediatric Oncology and Hematology Research Institute, Blokhin' National Medical Research Cancer Center of the Ministry of Health of Russia, Moscow, Russia., Kondratenko SN; Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Sechenov' First Moscow State Medical University of the Ministry of Health of Russia, Moscow, Russia., Ilyin MV; Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia, Yaroslavl, Russia.

المصدر: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2023 Jul 20; Vol. 38 (4), pp. 339-347. Date of Electronic Publication: 2023 Jul 20 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: eCollection Cited Medium: Internet ISSN: 2363-8915 (Electronic) Linking ISSN: 23638915 NLM ISO Abbreviation: Drug Metab Pers Ther Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Drug-Related Side Effects and Adverse Reactions*/genetics, Humans ; Female ; Cytochrome P-450 CYP2D6/genetics ; Cytochrome P-450 CYP3A/genetics ; Cytochrome P-450 CYP2C19/genetics ; Pharmacogenomic Testing ; Cytochrome P-450 CYP2C9/genetics ; Genotype ; Tamoxifen/adverse effects

المؤلفون: Sychev DA; Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation (FSBEI FPE RMACPE MOH Russia), Moscow, Russian Federation.; Clinical Pharmacology and Therapy Department, Russian Medical Academy of Continuous Professional Education, 2/1 bld. 1 Barrikadnaya Str, 125993, Moscow, Russian Federation., Polyakova OA; Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation (FSBEI FPE RMACPE MOH Russia), Moscow, Russian Federation. docpolyakova.olga@gmail.com.; Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi, Russian Medical Academy of Continuous Professional Education, 2/1 bld. 1 Barrikadnaya Str, 125993, Moscow, Russian Federation. docpolyakova.olga@gmail.com., Sozaeva ZA; Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation (FSBEI FPE RMACPE MOH Russia), Moscow, Russian Federation.; Department of Molecular Medicine, Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education, 7/2 2nd Botkinskiy Drive, 125284, Moscow, Russian Federation., Mirzaev KB; Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation (FSBEI FPE RMACPE MOH Russia), Moscow, Russian Federation.; Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education, 7/2 2nd Botkinskiy Drive, 125284, Moscow, Russian Federation., Ostroumova OD; Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation (FSBEI FPE RMACPE MOH Russia), Moscow, Russian Federation.; Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi, Russian Medical Academy of Continuous Professional Education, 2/1 bld. 1 Barrikadnaya Str, 125993, Moscow, Russian Federation.

المصدر: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension [High Blood Press Cardiovasc Prev] 2023 Mar; Vol. 30 (2), pp. 151-165. Date of Electronic Publication: 2023 Feb 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9421087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1985 (Electronic) Linking ISSN: 11209879 NLM ISO Abbreviation: High Blood Press Cardiovasc Prev Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases* , Hypertension*, Humans ; Cytochrome P-450 CYP2C19/genetics ; Polymorphism, Genetic ; Gene Frequency ; Risk Factors

المؤلفون: Sinitsina II; Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Boyarko AV; Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Temirbulatov II; Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation.; Laboratory of Human Population Genetics, Research Centre for Medical Genetics, Moscow, Russia., Sychev DA; Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Akmalova KA; Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Sozaeva ZA; Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Grishina EA; Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Mirzaev KB; Laboratory of Human Population Genetics, Research Centre for Medical Genetics, Moscow, Russia.; Department of Molecular Medicine, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Asoskova AV; Department of Dermatovenerology and Cosmetology, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation., Fisenko VP; Department of Pharmacology, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.

المصدر: Drug metabolism and personalized therapy [Drug Metab Pers Ther] 2022 Dec 29; Vol. 38 (2), pp. 163-168. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2023).

نوع المنشور: Observational Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: De Gruyter Country of Publication: Germany NLM ID: 101653409 Publication Model: eCollection Cited Medium: Internet ISSN: 2363-8915 (Electronic) Linking ISSN: 23638915 NLM ISO Abbreviation: Drug Metab Pers Ther Subsets: MEDLINE

مواضيع طبية MeSH: Aryl Hydrocarbon Hydroxylases*/genetics , Aryl Hydrocarbon Hydroxylases*/metabolism , Hypertension*/drug therapy , Hypertension*/genetics, Humans ; Losartan/therapeutic use ; Losartan/metabolism ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/metabolism ; Cytochrome P-450 CYP2C9/genetics ; Uric Acid ; Polymorphism, Genetic/genetics

المؤلفون: Sychev DA; Department of Pharmacology, Federal State Budgetary Educational Institution of Higher Professional Education 'Saratov State Medical University named after V.I.Razumovsky' of the Ministry of Healthcare of the Russian Federation., Sokolov AV; Department of Clinical Pharmacology and Therapy named after B.E. Votchal, Rector of Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Reshetko OV; Department of Clinical Pharmacology and Therapy named after B.E. Votchal, Rector of Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Fisenko VP; Department of Pharmacology of the Institute of Biodesign and Modeling of Complex Systems of Science and Technology Park of Biomedicine, Federal State Autonomous Educational Institution of Higher Professional Education 'First Moscow State Medical University named after I.M. Sechenov (Sechenov University)' of the Ministry of Healthcare of the Russian Federation., Sychev IN; Department of Pharmacology, Federal State Budgetary Educational Institution of Higher Professional Education 'Saratov State Medical University named after V.I.Razumovsky' of the Ministry of Healthcare of the Russian Federation., Grishina EA; Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Bochkov PO; Department of Personalized Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Shevchenko RV; Department of Personalized Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Abdullaev SP; Department of Molecular Medicine of Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Health of the Russian Federation., Denisenko NP; Department of Personalized Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Ivashchenko DV; Research Laboratory of Genomic Predictors of Adverse Drug Reactions at the Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation., Sozaeva ZA; Department of Molecular Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation., Kachanova AA; Department of Molecular Medicine, Research Centre of Molecular and Personalized Medicine, Federal State Budgetary Educational Institution of Further Professional Education 'Russian Medical Academy of Continuous Professional Education' of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation.

المصدر: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2022 Dec 01; Vol. 32 (9), pp. 301-307. Date of Electronic Publication: 2022 Oct 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101231005 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-6880 (Electronic) Linking ISSN: 17446872 NLM ISO Abbreviation: Pharmacogenet Genomics Subsets: MEDLINE

مواضيع طبية MeSH: Atrial Fibrillation*/drug therapy , Atrial Fibrillation*/genetics , Cytochrome P-450 CYP3A*/genetics , Cytochrome P-450 CYP3A*/metabolism, Female ; Humans ; Male ; ATP Binding Cassette Transporter, Subfamily B/genetics ; Genotype ; Polymorphism, Genetic ; Prothrombin Time ; Rivaroxaban/adverse effects ; Aged